Press release content from Business Wire. The AP news staff was not involved in its creation.
Europe Virtual Clinical Trials Market (2020 to 2026) - by Study Type, Indication and Country - ResearchAndMarkets.com
February 16, 2021 GMT
DUBLIN (BUSINESS WIRE) Feb 16, 2021
ADVERTISEMENT
Another name for virtual trials is decentralized trials. Virtual trials have a major role to play in the current COVID-19 pandemic and are likely to be a rule in the ways trials and real-world research are run. A virtual technique permits people to participate in the trial from the comfort of their homes which ensures that studies can be continued even when site visits are not feasible. Furthermore, it is a unique method of gathering secure and effective data from participants of clinical researches.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Medable Hires Parag Vaish as Chief Product Officer to Transform Clinical Trial Experience for Patients and Clinicians
January 26, 2021 GMT
Parag Vaish, Chief Product Officer, Medable (Photo: Business Wire)
PALO ALTO, Calif. (BUSINESS WIRE) Jan 26, 2021
Medable Inc, the leading cloud platform for patient-centered drug development, today announced the hiring of Parag Vaish as Chief Product Officer. Vaish is an established product leader with a strong track record transforming industries through product innovation. He has a unique background in healthcare and consumer markets, having served in product leadership roles at Tesla, Epocrates (part of athenahealth), and StubHub during critical phases in each company’s life cycle. Vaish also has prior experience at Google, NBC News, Microsoft and Disney.
Press release content from Business Wire. The AP news staff was not involved in its creation.
North America Virtual Clinical Trials Market 2020-2026 by Study Type, Indication, Country, Industry Analysis and Forecast - ResearchAndMarkets.com
January 26, 2021 GMT
DUBLIN (BUSINESS WIRE) Jan 26, 2021
ADVERTISEMENT
The North America Virtual Clinical Trials Market is expected to witness market growth of 4.8% CAGR during the forecast period (2020-2026).
The market is significantly driven by growth in R&D activities, the growing digitization in healthcare, and the adoption of telehealth. Moreover, advances in technology, collaborations between clinical research companies, biotechnology companies, and pharmaceutical and support initiatives from governments are expected to boost the market.